ArticleMedComm2023

SEMA3B-AS1 suppresses colorectal carcinoma progression by inhibiting Semaphorin 3B-dependent VEGF signaling pathway activation.

Yi-Qing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.